These compounds may interact with:
Integrin beta-1
Potentially involved in: mental depression; carcinoma; schizophrenia; cancer; multiple endocrine neoplasia type 2a; vascular disease; arthritis; hypersensitivity reaction type ii disease; calcinosis; non-small cell lung carcinoma; squamous cell carcinoma; cardiomyopathy, dilated; endometriosis; gliosis; heart failure; liver cirrhosis, experimental; neoplasm invasiveness; neoplasm metastasis; cardiomyopathies; astrocytoma, pilocytic
Disease data sourced from Pharos.